Profile of activity of κ receptor agonists in the rabbit vas deferens

European Journal of Pharmacology

Volumn 110, Issue 3, 1985, Pages 317-322

  Hayes, Ann ^a   Kelly, Alison ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Rabbit vas deferens; Receptor agonist

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 9 AMINO 4 CYCLOPROPYLMETHYL 3,4,5,6 TETRAHYDRO 2H 1,5 METHANO 1,4 BENZODIAZOCINE; BETA FUNALTREXAMINE; BREMAZOCINE; BUTORPHANOL; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ETHYLKETAZOCINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KETAZOCINE; MORPHINE; N (TETRAHYDROFURFURYL)NORMETAZOCINE; N ALLYLNORMETAZOCINE; NALORPHINE; NALOXONE; TIFLUADOM; UNCLASSIFIED DRUG;

9 AMINO 4 CYCLOPROPYLMETHYL 3,4,5,6 TETRAHYDRO 2H 1,5 METHANO 1,4 BENZODIAZOCINE; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; BIOLOGICAL MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMPARISON; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; GREAT BLOOD VESSEL; MALE GENITAL SYSTEM; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROXORPHAN; RAT; VAS DEFERENS;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMAL; BENZODIAZEPINES; BENZOMORPHANS; BUTORPHANOL; CYCLAZOCINE; ETHYLKETOCYCLAZOCINE; IN VITRO; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NALORPHINE; NALOXONE; PYRROLIDINES; RABBITS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; VAS DEFERENS;

EID: 0021793955     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(85)90558-8     Document Type: Article

References (16)

1. Further investigations into the properties of agonists for the κ opiate receptor
2. A new example of a morphine-sensitive neuro-effector junction; adrenergic transmission in the mouse vas deferens
3. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey
4. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allynoroxymorphone (naloxone)
5. A kappa opioid effect; increased urination in the rat
6. Endogenous opioid peptides; multiple agonists and receptors
7. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
8. Rabbit vas deferens; a specific bioassay for opioid κ-receptor agonists
9. Proxorphan (BL-5572), a novel oxamorphinan mixed agonist/antagonist analgetic agent
10. Bremazocine; a potent, long-acting opiate kappa agonist
11. Unexpected opioid activity in a known class of drug
12. Antinociceptive activity of clonidine in the mouse, rat and dog
13. Opiate receptors in the rat vas deferens
14. U-50,488; a selective and structurally novel non-mu (kappa) opioid agonist
15. Pharmacological characterisation in vivo of the novel opiate beta-funaltrexamine
16. Pharmacological profiles of β-funaltrexamine (β-FNA) and β-chlornaltrexamine (β-CNA) on the mouse vas deferens preparation